A Single-center, Prospective, Single-arm Clinical Study Exploring the Treatment of Newly Diagnosed Multiple Myeloma Patients With t(11;14) Suitable for Transplantation Using the SonKRd Regimen

NCT07709884 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed Multiple Myeloma
T(11;14)
Sotoclax
Carfilzomib

Interventions

DRUG: Sotoclax
DRUG: Carfilzomib
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

The First Affiliated Hospital of Soochow University